EOLS
Evolus IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$288.87M
P/E Ratio
—
EPS
$-0.80
Beta
1.00
52W High
$12.28
52W Low
$3.86
50-Day MA
$4.54
200-Day MA
$6.42
Dividend Yield
—
Profit Margin
-17.40%
Forward P/E
43.48
PEG Ratio
—
About Evolus Inc
Evolus, Inc., a high-performance beauty company, provides aesthetic medical products for physicians and their patients in the United States. The company is headquartered in Newport Beach, California.
Fundamentals
| Revenue (TTM) | $297.18M |
| Gross Profit (TTM) | $197.11M |
| EBITDA | $-30.09M |
| Operating Margin | -0.32% |
| Return on Equity | -18730.00% |
| Return on Assets | -10.20% |
| Revenue/Share (TTM) | $4.61 |
| Book Value | $-0.35 |
| Price-to-Book | 53.71 |
| Price-to-Sales (TTM) | 0.97 |
| EV/Revenue | 1.29 |
| EV/EBITDA | -21.50 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 14.40% |
| Shares Outstanding | $65.06M |
| Float | $49.24M |
| % Insiders | 16.31% |
| % Institutions | 75.99% |
Historical Volatility
HV 10-Day
54.71%
HV 20-Day
53.72%
HV 30-Day
105.10%
HV 60-Day
81.19%
HV Rank
87.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.67 target)
1
Strong Buy5
Buy1
HoldData last updated: 4/15/2026